Emerging Therapies Transforming IgA Nephropathy Care
IgA nephropathy (IgAN) treatment is advancing with new therapies targeting the disease’s roots rather than just managing symptoms. Innovations like Calliditas’ TARPEYO and Novartis’ iptacopan illustrate these breakthroughs, focusing on core disease drivers. Personalized and combination therapies further enhance treatment options, indicating a brighter outlook for those affected by this chronic kidney condition. Why Patients […]
3 minute read